The impact of diabetes mellitus on medical complication and mortality rates among inpatients with bullous pemphigoid

被引：0
|
作者：
Shreya Patel
Salma Ahsanuddin
Joshua B. Cadwell
W. Clark Lambert
机构：
[1] Department of Dermatology,
[2] Rutgers New Jersey Medical School,undefined
[3] Department of Pathology,undefined
[4] Immunology and Laboratory Medicine,undefined
[5] Rutgers New Jersey Medical School,undefined
来源：
Irish Journal of Medical Science (1971 -) | 2022年 / 191卷
关键词：
Bullous pemphigoid; Complications; Diabetes; Inpatient; Mortality; National Inpatient Sample;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1669 / 1675
页数：6
相关论文
共 50 条
  • [21] Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors
    Gravani, A.
    Gaitanis, G.
    Tsironi, T.
    Tigas, S.
    Bassukas, I. D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : E438 - E439
  • [22] Outcomes for general medical inpatients with diabetes mellitus and new hyperglycaemia
    Baker, Scott T.
    Chiang, Cherie Y.
    Zajac, Jeffrey D.
    Bach, Leon A.
    Jerums, George
    Maclsaac, Richard J.
    MEDICAL JOURNAL OF AUSTRALIA, 2008, 188 (06) : 340 - 343
  • [23] Commentary on 'Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors'
    Fania, L.
    Di Zenzo, G.
    Mazzanti, C.
    Abeni, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (12) : E439 - E440
  • [24] HIGHER INCIDENCE OF DIABETES-MELLITUS IN PATIENTS WITH BULLOUS PEMPHIGOID - A CASE-CONTROL STUDY
    CHUANG, TY
    KORKIJ, W
    SOLTANI, K
    CLAYMAN, J
    COOK, J
    CLINICAL RESEARCH, 1984, 32 (02): : A255 - A255
  • [25] INCREASED FREQUENCY OF DIABETES-MELLITUS IN PATIENTS WITH BULLOUS PEMPHIGOID - A CASE-CONTROL STUDY
    CHUANG, TY
    KORKIJ, W
    SOLTANI, K
    CLAYMAN, J
    COOK, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (06) : 1099 - 1102
  • [26] Usefulness of subclassification of adult diabetes mellitus among inpatients in Japan
    Saito, Kohei
    Inoue, Tatsuhide
    Ariyasu, Hiroyuki
    Shimada, Toshio
    Itoh, Hiroshi
    Tanaka, Issei
    Terao, Chikashi
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (04) : 706 - 713
  • [27] Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid
    Leisti, Paivi
    Pankakoski, Anna
    Jokelainen, Jari
    Huilaja, Laura
    Panelius, Jaana
    Tasanen, Kaisa
    Varpuluoma, Outi
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [28] Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre
    Gual, A.
    Mascaro, J. M., Jr.
    Rojas-Farreras, S.
    Guilabert, A.
    Julia, M.
    Iranzo, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (04) : 500 - 506
  • [29] Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus
    Hechter, Rulin C.
    Qian, Lei
    Luo, Yi
    Grant, Deborah S. Ling
    Baxter, Roger
    Klein, Nicola P.
    Nunley, Karen Valdez
    Aukes, Laurie
    Hogea, Cosmina
    Krishnarajah, Girishanthy
    Patterson, Brandon J.
    Im, Theresa M.
    Tseng, Hung Fu
    VACCINE, 2019, 37 (01) : 195 - 201
  • [30] The Risk Factors of Bullous Pemphigoid and Associated Risk between Bullous Pemphigoid and Dipeptidyl Peptidase-IV Inhibitors in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study
    Guo, Jia-Yin
    Chen, Hsin Hung
    Yang, Yu-Cih
    Chen, Ching-Chu
    DIABETES, 2019, 68
12345